Ghader Mohammadnezhad

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Multidrug Resistant

Metastatic Colorectal Cancer

Top Venues

Journal of gastrointestinal cancer

Cost effectiveness and resource allocation : C/E

Journal of cosmetic dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Ghader Mohammadnezhad, Farhad Assarzadegan, Mohsen Koosha, Hadi Esmaily
Eicosapentaenoic acid versus placebo as adjunctive therapy in chronic migraine: A randomized controlled trial. Headache (2024)
Ghader Mohammadnezhad, Hadi Esmaily, Maryam Talebi, Matin Jafari
Atezolizumab and Bevacizumab Targeted-Therapy in Advanced Hepatocellular Carcinoma: A Systematic Review of Cost-effectiveness Analyses. Journal of gastrointestinal cancer 55 (2) (2024)
Ghader Mohammadnezhad, Hadi Esmaily, Maryam Talebi, Matin Jafari
Atezolizumab and Bevacizumab Targeted-Therapy in Advanced Hepatocellular Carcinoma: A Systematic Review of Cost-effectiveness Analyses. Journal of gastrointestinal cancer (2024)
Nasibeh Ghalandari, Aida Edalatkhah Tatafi, Ghader Mohammadnezhad, Maryam Nassimi, Hadi Esmaily
Comparing the efficacy of three methods of permethrin application in pediculosis capitis: A randomized clinical trial. Journal of cosmetic dermatology (2023)
Ghader Mohammadnezhad, Behniya Azadmehr, Mehdi Mirheidari, Nazila Yousefi
Cost-effectiveness analysis of dapagliflozin in the management of heart failure with reduced ejection fraction (HFrEF): a systematic review. Cost effectiveness and resource allocation : C/E 20 (1) (2022)
Ghader Mohammadnezhad, Behniya Azadmehr, Nazila Yousefi
Cost-effectiveness evaluation of mirabegron versus anti-muscarinics and third-line therapies: a systematic review. Expert review of pharmacoeconomics & outcomes research 22 (8) (2022)